Beamtree Expands into UK with NHS Confederation Partnership

An update from Beamtree Holdings Ltd ( (AU:BMT) ) is now available.

Beamtree Holdings Limited has announced a strategic partnership with the NHS Confederation to expand its presence in the UK healthcare market. This collaboration aims to replicate Beamtree’s successful ANZ membership model within the NHS hospital sector in England, Wales, and Northern Ireland. The partnership will establish a benchmarking collaborative, providing NHS trusts with access to advanced analytics, benchmarking services, and peer-to-peer learning communities. The initial contract is for five years, with an option to extend, and includes a significant investment by Beamtree to establish the platform in the UK. This move is a key part of Beamtree’s growth strategy, offering potential benefits to NHS trusts through enhanced data analytics and operational benchmarking.

The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

More about Beamtree Holdings Ltd

Beamtree Holdings Limited is a leading provider of AI decision support and data insights solutions, specializing in healthcare analytics and benchmarking. The company operates across Australia, New Zealand, Canada, and the Middle East, focusing on turning data into actionable insights to improve patient outcomes. Beamtree offers a wide range of analytics across four key product segments, supporting healthcare providers globally.

Average Trading Volume: 143,912

Technical Sentiment Signal: Buy

Current Market Cap: A$84.04M

Find detailed analytics on BMT stock on TipRanks’ Stock Analysis page.